Insights Into Classical Hodgkin Lymphoma (CHL)

Perspectives on treatment patterns of community physicians from across the US on the management of first-line and relapsed/refractory CHL

October 12, 2020

Faculty Chair

Radhakrishnan Ramchandren, MD

The University of Tennessee Medical Center, TN, US

Example Report

Start discovering the insights

View Report

DISCUSSION TOPICS OF THE MEETING

  • First-Line Treatment of CHL
  • Treatment of Relapsed/Refractory CHL
  • Key Takeaways and Meeting Evaluation

GEOGRAPHIC REPRESENTATION

  • The group of advisors will consist of community oncologists representative for the US.

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.